Cisatracurium besylate
Cisatracurium besylate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Cisatracurium besylate; Generic name: CISATRACURIUM BESYLATE; Manufacturer: Gland Pharma Limited.
| Brand name | Cisatracurium besylate |
|---|---|
| Generic name | CISATRACURIUM BESYLATE |
| Manufacturer | Gland Pharma Limited |
| Used for | 1 INDICATIONS AND USAGE Cisatracurium besylate injection is indicated: • as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age • to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICU • to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older Limitations of Use Cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. Cisatracurium besylate injection is a nondepolarizing neuromuscular blocker indicated: as |
| Dosage | 2 DOSAGE AND ADMINISTRATION Store cisatracurium besylate injection with the cap and ferrule intact and in a manner that minimizes the possibility of selecting the wrong product (2.1) Administer intravenously only by or under the supervision of experienced clinicians familiar with drug’s actions and possible complications (2.1) Use only if personnel and facilities for resuscitation and life support, and a cisatracurium besylate injection antagonist are immediately available (2.1) Use a peripheral |
| Active ingredient(s) | CISATRACURIUM BESYLATE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0bacc37a-5e7f-4f05-9206-56fc8041c1ad |